Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations

Development of new bexarotene-loaded mesoporous silica systems for topical pharmaceutical formulations

The present study reports the first time use of MCM-41 mesoporous silica as highly efficient carrier for bexarotene - an antineoplastic agent specific for cutaneous T-cell lymphoma treatment. Bexarotene is highly toxic and poor-water soluble, having low bioavailability in the conventional pharmaceut...

Full description

Bibliographic Details
Main Authors:	Aurelia Vasile, Maria Ignat, Mirela Fernanda Zaltariov, Liviu Sacarescu, Iulian Stoleriu, Dan Draganescu, Mihai Dumitras, Lacramioara Ochiuz
Format:	Article
Language:	English
Published:	Slovenian Chemical Society 2018-03-01
Series:	Acta Chimica Slovenica
Subjects:	aminofunctionalized mesoporous silica carrier bexarotene release
Online Access:	https://journals.matheo.si/index.php/ACSi/article/view/3641

Similar Items

Multifractal Analysis and Experimental Evaluation of MCM-48 Mesoporous Silica as a Drug Delivery System for Metformin Hydrochloride
by: Mousa Sha’at, et al.
Published: (2024-12-01)

Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
by: Katsunori Manaka, et al.
Published: (2024-08-01)

Bexarotene-Induced Hypertriglyceridemia: A Case Report
by: Chris Maminakis, et al.
Published: (2018-04-01)

Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement
by: Fu Xiao, et al.
Published: (2022-10-01)

Photodegradation of Bexarotene and Its Implication for Cytotoxicity
by: Agata Kryczyk-Poprawa, et al.
Published: (2021-08-01)

Functionalized Mesoporous Silica as Doxorubicin Carriers and Cytotoxicity Boosters
by: Carmen Racles, et al.
Published: (2022-05-01)

Amine-Impregnated Dendritic Mesoporous Silica for the Adsorption of Formaldehyde
by: Ji Myeong Lee, et al.
Published: (2023-12-01)

A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats
by: Shuyue Ren, et al.
Published: (2020-09-01)

Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
by: Verónica Vidal, et al.
Published: (2021-04-01)

Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
by: Iván Cervigón-González, et al.
Published: (2011-02-01)

RXRα agonist bexarotene attenuates radiation-induced skin injury by relieving oxidative stress
by: Sheng Jiang, et al.
Published: (2022-06-01)

Indolent adult T‐cell leukaemia‐lymphoma successfully treated with bexarotene in an eldery patient
by: Maho Nakashima, et al.
Published: (2023-12-01)

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy
by: Kayo Tanita, et al.
Published: (2017-04-01)

Metoprolol Tartrate Drug Loading and Release from Prepared Mesoporous Silica; Kinetic of Adsorption and Release
by: Manar Abdulameer Sachit, et al.
Published: (2024-04-01)

Pioneering Advances and Innovative Applications of Mesoporous Carriers for Mitochondria-Targeted Therapeutics
by: Mohamad Anas Al Tahan, et al.
Published: (2024-11-01)

Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses
by: Jacques Rouanet, et al.
Published: (2022-07-01)

Bexarotene Reduces Production of CCL22 From Tumor-Associated Macrophages in Cutaneous T-Cell Lymphoma
by: Kayo Tanita, et al.
Published: (2019-09-01)

An Assessment of Mesoporous Silica Nanoparticle Architectures as Antigen Carriers
by: Xinyue Huang, et al.
Published: (2020-03-01)

Bexarotene ameliorated the pulmonary inflammation and M1 polarization of alveolar macrophages induced by cigarette smoke via PPARγ/HO-1
by: Haoshen Feng, et al.
Published: (2024-12-01)

Designing advanced functional periodic mesoporous organosilicas for biomedical applications
by: Dolores Esquivel, et al.
Published: (2014-03-01)

A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)
by: Sean DeAngelo, et al.
Published: (2020-12-01)

Curcumin and Capsaicin-Loaded Ag-Modified Mesoporous Silica Carriers: A New Alternative in Skin Treatment
by: Ivalina Trendafilova, et al.
Published: (2022-09-01)

Inhibition of MAPT enhances the effect of bexarotene and attenuates the damage after traumatic brain injury using in vivo and in vitro experiments
by: Haihai Dong, et al.
Published: (2020-10-01)

Chiral Mesoporous Silica Materials: A Review on Synthetic Strategies and Applications
by: Mingshu Cui, et al.
Published: (2020-08-01)

Immobilization of Metronidazole on Mesoporous Silica Materials
by: Klára Szentmihályi, et al.
Published: (2022-10-01)

Growth and Functionalization of Particle-Based Mesoporous Silica Films and Their Usage in Catalysis
by: Pei-Hsuan Wu, et al.
Published: (2019-04-01)

Synthesis and characterization of hollow mesoporous silica nanocomposites containing phosphorescent pigment and doxycycline
by: Zahra Alam, et al.
Published: (2023-03-01)

Inhibitory effect of doxorubicin-loaded mesoporous silica nanoparticles on bladder cancer cells
by: SU Qiaoling, et al.
Published: (2021-12-01)

Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
by: Alejandro Baeza, et al.
Published: (2020-10-01)

BITEMPLATE SYNTHESIS OF MESOPOROUS SILICAS WITH THIOUREA GROUPS
by: O. I. Gona, et al.
Published: (2009-06-01)

Characterization and Comparison of Mesoporous Silica Particles for Optimized Drug Delivery
by: Xinyue Huang, et al.
Published: (2014-01-01)

Mesoporous Silica-Based Catalysts for Biodiesel Production: A Review
by: Is Fatimah, et al.
Published: (2023-06-01)

Study of the physicochemical characteristics of mesoporous carbons obtained by using SBA-16 mesoporous silica as template
by: Leidy Hoyos, et al.
Published: (2010-01-01)

Encapsulation of drug into mesoporous silica by solvent evaporation: A comparative study of drug characterization in mesoporous silica with various molecular weights
by: Arif Budiman, et al.
Published: (2021-12-01)

Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs
by: Aura Rocío Hernández, et al.
Published: (2024-12-01)

Synthesis of mesoporous silica nanoparticles by sol–gel as nanocontainer for future drug delivery applications
by: Naiara I. Vazquez, et al.
Published: (2017-05-01)

Degradation of Mesoporous Silica Materials in Biological Milieu: The Gateway for Therapeutic Applications
by: Sergio E. Moya, et al.
Published: (2024-10-01)

Mesoporous Silica Nanoparticles for Bio-Applications
by: Violeta-Carolina Niculescu
Published: (2020-02-01)

iTRAQ-derived quantitative proteomics uncovers the neuroprotective property of bexarotene in a mice model of cerebral ischemia–reperfusion injury
by: Hailin Liu, et al.
Published: (2022-05-01)

Influence of Mesoporous Silica Functionalization and Pore Size on Resveratrol Release Profiles
by: Daniel Lincu, et al.
Published: (2019-10-01)